InflaRx NV (FRA:IF0) Cyclically Adjusted FCF per Share: €-0.95 (As of Mar. 2026)


FRA:IF0 InflaRx NV FRA:IF0
36 GF Score
Price €1.69
! 5 Warning Signs
View Full Analysis

What is InflaRx NV Cyclically Adjusted FCF per Share?

InflaRx NV FRA:IF0 -8.76% 36 Cyclically Adjusted FCF per Share is €-0.95 as of Mar. 2026. GuruFocus rates FRA:IF0 with a GF Score™ of 36/100. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

InflaRx NV's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.102. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.95 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-12), InflaRx NV's current stock price is €1.687. InflaRx NV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.95. InflaRx NV's Cyclically Adjusted Price-to-FCF of today is .


InflaRx NV  (FRA:IF0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


InflaRx NV Cyclically Adjusted FCF per Share Related Terms


InflaRx NV Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for InflaRx NV's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV Cyclically Adjusted FCF per Share Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.07

InflaRx NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.07 -0.95

FRA:IF0 vs BCYC, ELDN, ZNTL: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, InflaRx NV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Cyclically Adjusted Price-to-FCF falls into.


FRA:IF0
36GF Score
InflaRx NV FRA:IF0
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InflaRx NV's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.102/131.2583*131.2583
=-0.102

Current CPI (Mar. 2026) = 131.2583.

InflaRx NV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 100.717 0.000
201609 0.000 101.017 0.000
201612 0.000 101.217 0.000
201703 -0.118 101.417 -0.153
201706 -0.107 102.117 -0.138
201709 -0.139 102.717 -0.178
201712 -0.159 102.617 -0.203
201803 -0.245 102.917 -0.312
201806 -0.228 104.017 -0.288
201809 -0.166 104.718 -0.208
201812 -0.253 104.217 -0.319
201903 -0.337 104.217 -0.424
201906 -0.404 105.718 -0.502
201909 -0.323 106.018 -0.400
201912 -0.620 105.818 -0.769
202003 -0.404 105.718 -0.502
202006 -0.295 106.618 -0.363
202009 -0.311 105.818 -0.386
202012 -0.345 105.518 -0.429
202103 -0.309 107.518 -0.377
202106 -0.177 108.486 -0.214
202109 -0.225 109.435 -0.270
202112 -0.265 110.384 -0.315
202203 -0.291 113.968 -0.335
202206 -0.283 115.760 -0.321
202209 -0.072 118.818 -0.080
202212 -0.121 119.345 -0.133
202303 -0.235 122.402 -0.252
202306 -0.196 123.140 -0.209
202309 -0.090 124.195 -0.095
202312 -0.185 123.773 -0.196
202403 -0.253 125.038 -0.266
202406 -0.206 125.882 -0.215
202409 -0.164 126.198 -0.171
202412 -0.202 127.041 -0.209
202503 -0.222 127.779 -0.228
202506 -0.112 128.412 -0.114
202509 -0.135 129.255 -0.137
202512 -0.067 129.361 -0.068
202603 -0.102 131.258 -0.102

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.95 mean?
InflaRx NV (FRA:IF0) has a Cyclically Adjusted FCF per Share of €-0.95 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on InflaRx NV and its competitors.
Is InflaRx NV's Cyclically Adjusted FCF per Share too high?
InflaRx NV's current Cyclically Adjusted FCF per Share is €-0.95. Overall, InflaRx NV has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Cyclically Adjusted FCF per Share compare to BCYC and ELDN?
InflaRx NV's Cyclically Adjusted FCF per Share of €-0.95 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on InflaRx NV and its competitors. InflaRx NV's current Cyclically Adjusted FCF per Share is €-0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (FRA:IF0) has a current Cyclically Adjusted FCF per Share of €-0.95. The current Cyclically Adjusted FCF per Share is €-0.95. InflaRx NV's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For InflaRx NV (FRA:IF0), the current Cyclically Adjusted FCF per Share is €-0.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IFRX:USA
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
36GF Score

Get the complete analysis for FRA:IF0

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.69
Price